PMID- 17612311
OWN - NLM
STAT- MEDLINE
DCOM- 20070926
LR  - 20151119
IS  - 8755-0229 (Print)
IS  - 8755-0229 (Linking)
VI  - 22
IP  - 6
DP  - 2007 May-Jun
TI  - Managing difficult-to-treat asthma: Lessons from a center of excellence in 
      allergy and asthma care.
PG  - 350-8
AB  - One in four asthma patients may not have their condition adequately controlled 
      despite being treated according to current practice guidelines, and these 
      patients experience persistent symptoms, frequent exacerbations, and high 
      healthcare utilization. The Allergy and Asthma Center, a recognized center of 
      excellence in the treatment of allergy and asthma, is based on a patient-first 
      philosophy, and this article explains how the practice operates and the 
      importance of maintaining efficient office flow, implementing technology, and 
      building a caring and dedicated staff Because asthma patients are often referred 
      from primary care physicians, many present with difficult-to-treat disease. Even 
      though many of these patients have received inhaled corticosteroids either alone 
      or in combination with other medications, their condition still remains not well 
      controlled. Serum total immunoglobulin E (IgE) is commonly elevated in patients 
      with dfficult-to-treat asthma, and consequently, the IgE blocker omalizumab may 
      be a viable option in this setting.
FAU - Smits, William
AU  - Smits W
AD  - The Allergy and Asthma Center, 7230 Engle Road, Suite 300, Fort Wayne, IN 46804, 
      USA. wlsmits@aol.com
FAU - Letz, Kevin
AU  - Letz K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Med Pract Manage
JT  - The Journal of medical practice management : MPM
JID - 8605494
RN  - 0 (Antibodies, Anti-Idiotypic)
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - 2P471X1Z11 (Omalizumab)
RN  - 37341-29-0 (Immunoglobulin E)
MH  - Allergy and Immunology/*organization & administration
MH  - Ambulatory Care Facilities/*organization & administration/standards
MH  - Antibodies, Anti-Idiotypic
MH  - Antibodies, Monoclonal/therapeutic use
MH  - Antibodies, Monoclonal, Humanized
MH  - Asthma/*drug therapy/therapy
MH  - *Awards and Prizes
MH  - *Benchmarking
MH  - Drug Monitoring
MH  - Humans
MH  - Immunoglobulin E/blood/drug effects
MH  - Indiana
MH  - Medical Records Systems, Computerized
MH  - Omalizumab
MH  - Patient Satisfaction
MH  - Staff Development
MH  - Treatment Outcome
EDAT- 2007/07/07 09:00
MHDA- 2007/09/27 09:00
CRDT- 2007/07/07 09:00
PHST- 2007/07/07 09:00 [pubmed]
PHST- 2007/09/27 09:00 [medline]
PHST- 2007/07/07 09:00 [entrez]
PST - ppublish
SO  - J Med Pract Manage. 2007 May-Jun;22(6):350-8.